Precise mapping of an IGF-I-binding site on the IGF-1R

Biochemical Journal

Volumn 401, Issue 1, 2007, Pages 269-277

  Keyhanfar, Mehrnaz ^a,b   Booker, Grant W ^a   Whittaker, Jonathan ^c   Wallace, John C ^a   Forbes, Briony E ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b BU ALI SINA UNIVERSITY   (Iran)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Binding epitope; Cancer; Insulin like growth factor (IGF); Monoclonal antibody; Type 1 insulin like growth factor receptor (IGF 1R)

Indexed keywords

BINDING EPITOPE; INSULIN-LIKE GROWTH FACTOR (IGF); MONOCLONAL ANTIBODY; TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (IGF-1R);

ANTIBODIES; BINDING ENERGY; CELL CULTURE; GROWTH KINETICS; TUMORS;

PROTEINS;

CYSTEINE; INSULIN RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 7C2; MONOCLONAL ANTIBODY 9E11; PHENYLALANINE; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; BINDING SITE; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BINDING SITES; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CRICETINAE; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; MICE; PEPTIDE MAPPING; POINT MUTATION; PROTEIN CONFORMATION; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN;

CHIMAERIFORMES;

EID: 33846332792     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20060890     Document Type: Article

References (45)

1. Pollak, M. N., Schernhammer, E. S. and Hankinson, S. E. (2004) Insulin-like growth factors and neoplasia. Nat. Rev. Cancer 4, 505-518
2. Adams, T. E., Epa, V. C., Garrett, T. P. and Ward, C. W. (2000) Structure and function of the type 1 insulin-like growth factor receptor. Cell. Mol. Life Sci. 57, 1050-1093
3. De Meyts, P. and Whittaker, J. (2002) Structural biology of insulin and IGF1 receptors: implications for drug design. Nat. Rev. Drug Discov. 1, 769-783
4. Kato, H., Faria, T. N., Stannard, B., Roberts, Jr, C. T. and Le Roith, D. (1994) Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. Mol. Endocrinol. 8, 40-50
5. O'Connor, R. (2003) Regulation of IGF-I receptor signaling in tumor cells. Horm. Metab. Res. 35, 771-777
6. Adams, T. E., McKern, N. M. and Ward, C. W. (2004) Signalling by the type 1 insulin-like growth factor receptor: interplay with the epidermal growth factor receptor. Growth Factors 22, 89-95
7. Yee, D. (2006) Targeting insulin-like growth factor pathways. Br. J. Cancer 94, 465-468
8. Miller, B. S. and Yee, D. (2005) Type I insulin-like growth factor receptor as a therapeutic target in cancer. Cancer Res. 65, 10123-10127
9. Garrett, T. P., McKern, N. M., Lou, M., Frenkel, M. J., Bentley, J. D., Lovrecz, G. O., Elleman, T. C., Cosgrove, L. J. and Ward, C. W. (1998) Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor. Nature 394, 395-399
10. Whittaker, J., Groth, A. V., Mynarcik, D. C., Pluzek, L., Gadsboll, V. L. and Whittaker, L. J. (2001) Alanine scanning mutagenesis of a type 1 insulin-like growth factor receptor ligand binding site. J. Biol. Chem. 276, 43980-43986
11. Sorensen, H., Whittaker, L., Hinrichsen, J., Groth, A. and Whittaker, J. (2004) Mapping of the insulin-like growth factor II binding site of the Type I insulin-like growth factor receptor by alanine scanning mutagenesis. FEBS Lett. 565, 19-22
12. Hoyne, P. A., Elleman, T. C., Adams, T. E., Richards, K. M. and Ward, C. W. (2000) Properties of an insulin receptor with an IGF-1 receptor loop exchange in the cysteine-rich region. FEBS Lett. 469, 57-60
13. Gustafson, T. A. and Rutter, W. J. (1990) The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity: evidence from receptor chimeras. J. Biol. Chem. 265, 18663-18667
14. Denley, A., Cosgrove, L. J., Booker, G. W., Wallace, J. C. and Forbes, B. E. (2005) Molecular interactions of the IGF system. Cytokine Growth Factor Res. 16, 421-439
15. Denley, A., Bonython, E. R., Booker, G. W., Cosgrove, L. J., Forbes, B. E., Ward, C. W. and Wallace, J. C. (2004) Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Mol. Endocrinol. 18, 2502-2512
16. Kurose, T., Pashmforoush, M., Yoshimasa, Y., Carroll, R., Schwartz, G. P., Burke, G. T., Katsoyannis, P. G. and Steiner, D. F. (1994) Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the α-subunit of the insulin receptor: identification of a new insulin-binding domain in the insulin receptor. J. Biol. Chem. 269, 29190-29197
17. Wan, Z., Xu, B., Huang, K., Chu, Y. C., Li, B., Nakagawa, S. H., Qu, Y., Hu, S. Q., Katsoyannis, P. G. and Weiss, M. A. (2004) Enhancing the activity of insulin at the receptor interface: crystal structure and photo-cross-linking of A8 analogues. Biochemistry 43, 16119-16133
18. Xu, B., Hu, S. Q., Chu, Y. C., Huang, K., Nakagawa, S. H., Whittaker, J., Katsoyannis, P. G. and Weiss, M. A. (2004) Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor. Biochemistry 43, 8356-8372
19. Huang, K., Xu, B., Hu, S. Q., Chu, Y. C., Hua, Q. X., Qu, Y., Li, B., Wang, S., Wang, R. Y., Nakagawa, S. H. et al. (2004) How insulin binds: the B-chain α-helix contacts the L1 β-helix of the insulin receptor. J. Mol. Biol. 341, 529-550
20. Christoffersen, C. T., Bornfeldt, K. E., Rotella, C. M., Gonzales, N., Vissing, H., Shymko, R. M., ten Hoeve, J., Groffen, J., Heisterkamp, N. and De Meyts, P. (1994) Negative cooperativity in the insulin-like growth factor-I receptor and a chimaeric IGF-I/insulin receptor. Endocrinology 135, 472-475
21. Keyhanfar, M., Forbes, B. E., Cosgrove, L. J., Wallace, J. C. and Booker, G. W. (2006) Production and characterisation of monoclonal antibodies against insulin-like growth factor type 1 receptor (IGF-1R). Hybridoma 25, 230-237
22. Sell, C., Rubini, M., Rubin, R., Liu, J. P., Efstratiadis, A. and Baserga, R. (1993) Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc. Natl. Acad. Sci. U.S.A. 90, 11217-11221
23. Schumacher, R., Mosthaf, L., Schlessinger, J., Brandenburg, D. and Ullrich, A. (1991) Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors. J. Biol. Chem. 266, 19288-19295
24. Schumacher, R., Soos, M. A., Schlessinger, J., Brandenburg, D., Siddle, K. and Ullrich, A. (1993) Signaling-competent receptor chimaeras allow mapping of major insulin receptor binding domain determinants. J. Biol. Chem. 268, 1087-1094
25. Fagerstam, L. G., Frostell, A., Karlsson, R., Kullman, M., Larsson, A., Malmqvist, M. and Butt, H. (1990) Detection of antigen-antibody interactions by surface plasmon resonance: application to epitope mapping. J. Mol. Recognit. 3, 208-214
26. Forbes, B. E., Hartfield, P. J., McNeil, K. A., Surinya, K. H., Milner, S. J., Cosgrove, L. J. and Wallace, J. C. (2002) Characteristics of binding of insulin-like growth factor (IGF)-I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis. Eur. J. Biochem. 269, 961-968
27. Soos, M. A., Field, C. E., Lammers, R., Ullrich, A., Zhang, B., Roth, R. A., Andersen, A. S., Kjeldsen, T. and Siddle, K. (1992) A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity. J. Biol. Chem. 267, 12955-12963
28. Raychaudhuri, G., McCool, D. and Painter, R. H. (1985) Human IgG1 and its Fc fragment bind with different affinities to the Fc receptors on the humah U937, HL-60 and ML-1 cell lines. Mol. Immunol. 22, 1009-1019
29. Harlow, E. and Lane, D. (1999) Using Antibodies: a Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
30. Mynarcik, D. C., Williams, P. F., Schaffer, L., Yu, G. Q. and Whittaker, J. (1997) Identification of common ligand binding determinants of the insulin and insulin-like growth factor 1 receptors: insights into mechanisms of ligand binding. J. Biol. Chem. 272, 18650-18655
31. Crouch, S. P., Kozlowski, R., Slater, K. J. and Fletcher, J. (1993) The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J. Immunol. Methods 160, 81-88
32. Denley, A., Brierley, G. V., Carroll, J. M., Lindenberg, A., Booker, G. W., Cosgrove, L. J., Wallace, J. C., Forbes, B. E. and Roberts, Jr, C. T. (2006) Differential activation of insulin receptor isoforms by insulin-like growth factors is determined by the C-domain. Endocrinology 147, 1029-1036
33. Hailey, J., Maxwell, E., Koukouras, K., Bishop, W. R., Pachter, J. A. and Wang, Y. (2002) Neutralizing anti-insulin-like growth factor receptor 1 antibodies inhibit receptor function and induce receptor degradation in tumor cells. Mol. Cancer Ther. 1, 1349-1353
34. Ward, C. W., Hoyne, P. A. and Flegg, R. H. (1995) Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumor necrosis factor receptor Proteins 22, 141-153
35. Sundberg, E. J. and Mariuzza, R. A. (2002) Molecular recognition in antibody-antigen complexes. Adv. Protein Chem. 61, 119-160
36. Zhang, W., Gustafson, T. A., Rutter, W. J. and Johnson, J. D. (1994) Positively charged side chains in the insulin-like growth factor-1 C- and D-regions determine receptor binding specificity. J. Biol. Chem. 269, 10609-10613
37. Jansson, M., Andersson, G., Uhlen, M., Nilsson, B. and Kordel, J. (1998) The insulin-like growth factor (IGF) binding protein 1 binding epitope on IGF-I probed by heteronuclear NMR spectroscopy and mutational analysis. J. Biol. Chem. 273, 24701-24707
38. Bayne, M. L., Applebaum, J., Chicchi, G. G., Miller, R. E. and Cascieri, M. A. (1990) The roles of tyroslnes 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor. J. Biol. Chem. 265, 15648-15652
39. Epa, V. C. and Ward, C. W. (2006) Model for the complex between the insulin-like growth factor I and its receptor: towards designing antagonists for the IGF-1 receptor. Protein Eng. Des. Sel. 19, 377-384
40. Lu, D., Zhang, H., Ludwig, D., Persaud, A., Jimenez, X., Burtrum, D., Balderes, P., Liu, M., Bohlen, P., Witte, L. and Zhu, Z. (2004) Simultaneous blockade of both the epidermal growth factor receptor and the insulin-like growth factor receptor signaling pathways in cancer cells with a fully human recombinant bispecific antibody. J. Biol. Chem. 279, 2856-2865
41. Lu, D., Zhang, H., Koo, H., Tonra, J., Balderes, P., Prewett, M., Corcoran, E., Mangalampalli, V., Bassi, R., Anselma, D. et al. (2005) A fully human recombinant IgG-like bispecific antibody to both the epidermal growth factor receptor and the insulin-like growth factor receptor for enhanced antitumor activity. J. Biol. Chem. 280, 19665-19672
42. Maloney, E. K., McLaughlin, J. L., Dagdigian, N. E., Garrett, L. M., Connors, K. M., Zhou, X. M., Blattler, W. A., Chittenden, T. and Singh, R. (2003) An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. Cancer Res. 63, 5073-5083
43. Sachdev, D., Li, S. L., Hartell, J. S., Fujita-Yamaguchi, Y., Miller, J. S. and Yee, D. (2003) A chimaeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Cancer Res. 63, 627-635
44. Goetsch, L., Gonzalez, A., Leger, O., Beck, A., Pauwels, P. J., Haeuw, J. F. and Corvaia, N. (2005) A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts. Int. J. Cancer. 113, 316-328
45. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C. and Ferrin, T. E. (2004) UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612